Stability and Hopf bifurcation in an approachable haematopoietic stem cells model

Mathematical Biosciences
Hamad Talibi Alaoui, Radouane Yafia

Abstract

We consider the haematopoietic stem cells model (HSC) with one delay introduced by Mackey [M.C. Mackey, Unified hypothesis for the origin of aplastic anemia and periodic hematopoiesis, blood 51 (1978) 5; M.C. Mackey, Mathematical models of haematopoietic cell replication and control, in: The Art of Mathematical Modelling: Case Studies in Ecology, Physiology and Biofluids, H.G. Othmer, F.R. Adler, M.A. Lewis, J.C. Dallon (Eds), Prentice-Hall, New York, 1997, p. 149] and Andersen and Mackey [L.K. Andersen, M.C. Mackey, Resonance in periodic chemotherapy: a case study of acute myelogenous leukemia, J. theor. Biol. 209 (2001) 113]. There are two possible stationary states in the model. One of them is trivial and the second E( *)(tau) depending on the delay is non-trivial . This paper investigates the stability of the non-trivial state and occurrence of the Hopf bifurcation depending on time delay. We prove the existence and uniqueness of a critical values tau(0) and tau of the delay such that E( *)(tau) is asymptotically stable for tau<tau(0) and unstable for tau(0)<tau<tau . We show that E( *)(tau(0)) is a Hopf bifurcation critical point for an approachable model.

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.